AU2002349797A1 - Extended release compositions comprising as active compound venlafaxine hydrochloride - Google Patents

Extended release compositions comprising as active compound venlafaxine hydrochloride

Info

Publication number
AU2002349797A1
AU2002349797A1 AU2002349797A AU2002349797A AU2002349797A1 AU 2002349797 A1 AU2002349797 A1 AU 2002349797A1 AU 2002349797 A AU2002349797 A AU 2002349797A AU 2002349797 A AU2002349797 A AU 2002349797A AU 2002349797 A1 AU2002349797 A1 AU 2002349797A1
Authority
AU
Australia
Prior art keywords
active compound
extended release
release compositions
venlafaxine hydrochloride
compound venlafaxine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002349797A
Inventor
Yoram Sela
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Karma Pharm Ltd
Original Assignee
Karma Pharm Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Karma Pharm Ltd filed Critical Karma Pharm Ltd
Publication of AU2002349797A1 publication Critical patent/AU2002349797A1/en
Abandoned legal-status Critical Current

Links

AU2002349797A 2001-11-13 2002-11-07 Extended release compositions comprising as active compound venlafaxine hydrochloride Abandoned AU2002349797A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IL146462 2001-11-13

Publications (1)

Publication Number Publication Date
AU2002349797A1 true AU2002349797A1 (en) 2003-05-26

Family

ID=

Similar Documents

Publication Publication Date Title
HUP0500540A3 (en) Extended release compositions comprising as active compound venlafaxine hydrochloride
AU2002332019A1 (en) Adjuvant compositions
AU2002320251A1 (en) Compositions for improving mental performance
AU2002354251A1 (en) Bactericidal composition
AU2002363361A1 (en) Pharmaceutical compositions containing oxybutynin
AU2002342968A1 (en) Fatty acid compounds, preparation and uses thereof
AU2002337803A1 (en) Sustained release pharmaceutical compositions
IL149055A0 (en) Extended release composition comprising as active compound venlafaxine hydrochloride
AU2002337967A1 (en) Extended release composition containing tramadol
AU2003226748A1 (en) Compositions of venlafaxine base
AU2002309475A1 (en) Esmolol formulation
AU2002347377A1 (en) Sustained-release compositions
AU2003269177A1 (en) Antimicrobial compositions
AU2003241537A1 (en) Biguanide formulations
AU2003219117A1 (en) Extended release venlafaxine formulations
AU2002338201A1 (en) Anthelmintic composition
AU2002303293A1 (en) Triaza compound immunoregulatory agents
AU2002343016A1 (en) Heteregeneous catalyst compositions
AU2002349797A1 (en) Extended release compositions comprising as active compound venlafaxine hydrochloride
AU2002359695A1 (en) Aqueous ifosfamide composition
AU2003274655A1 (en) Pharmaceutical compositions containing venlafaxine
AU2003257295A1 (en) Solid compositions comprising gabapentin having improved stability
AU2002316457A1 (en) Coronatine as an abscission agent
AU2003296852A1 (en) Multiparticulate modified release composition comprising beraprost
AU2002338027A1 (en) Remedies for diseases caused by beta-amyloids containing 2-100beta inhibitor as the active ingredient